A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation.
作者信息
Corris P A, Kirby J A
出版信息
Clin Exp Immunol. 2005 Feb;139(2):176-8. doi: 10.1111/j.1365-2249.2005.02711.x.
Abstract
摘要
相似文献
1
A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation.
Clin Exp Immunol. 2005 Feb;139(2):176-8. doi: 10.1111/j.1365-2249.2005.02711.x.
2
[Immunosuppressive therapy after human lung transplantation--drugs presentation].
Pneumonol Alergol Pol. 2005;73(1):100-7.
3
Cytokines as predictive biomarkers of alloreactivity.
Clin Chim Acta. 2012 Sep 8;413(17-18):1354-8. doi: 10.1016/j.cca.2012.04.014. Epub 2012 Apr 20.
4
The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients.
Transpl Immunol. 2005 Mar;14(1):37-42. doi: 10.1016/j.trim.2004.11.001. Epub 2004 Dec 7.
5
Increased natural killer T-like cells are a major source of pro-inflammatory cytokines and granzymes in lung transplant recipients.
Respirology. 2012 Jan;17(1):155-63. doi: 10.1111/j.1440-1843.2011.02075.x.
6
[Hemostasis in pulmonary allografts in dogs].
J Chir (Paris). 1971 Oct;102(4):369-78.
7
Evolving immunosuppressive regimens for lung transplant recipients.
Semin Respir Crit Care Med. 2006 Oct;27(5):470-9. doi: 10.1055/s-2006-954605.
8
Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance.
Transpl Immunol. 2008 Apr;19(1):1-11. doi: 10.1016/j.trim.2008.01.004. Epub 2008 Feb 20.
9
One-stage bilateral allotransplantation of canine lungs; further studies. Early rejection and prolonged survival with immunosuppression.
J Thorac Cardiovasc Surg. 1972 Dec;64(6):897-906.
10
Conventional and novel approaches to immunosuppression.
Clin Chest Med. 2011 Jun;32(2):265-77. doi: 10.1016/j.ccm.2011.02.012.
引用本文的文献
1
Cytokines in Lung Transplantation.
Lung. 2022 Dec;200(6):793-806. doi: 10.1007/s00408-022-00588-1. Epub 2022 Nov 8.
2
BOS is associated with decreased HDAC2 from steroid resistant lymphocytes in the small airways.
Clin Exp Immunol. 2019 Feb;195(2):277-285. doi: 10.1111/cei.13221. Epub 2018 Oct 29.
3
Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation.
J Transl Med. 2018 Feb 15;16(1):31. doi: 10.1186/s12967-018-1403-0.
4
Bronchiolitis obliterans syndrome is associated with increased p-glycoprotein expression and loss of glucocorticoid receptor from steroid-resistant proinflammatory CD8 T cells.
Clin Exp Immunol. 2018 May;192(2):242-250. doi: 10.1111/cei.13103. Epub 2018 Feb 14.
5
Cytokine signatures of human whole blood for monitoring immunosuppression.
Cent Eur J Immunol. 2014;39(3):271-8. doi: 10.5114/ceji.2014.45936. Epub 2014 Oct 14.
6
Real-time, aptamer-based tracking of circulating therapeutic agents in living animals.
Sci Transl Med. 2013 Nov 27;5(213):213ra165. doi: 10.1126/scitranslmed.3007095.
7
Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome.
Clin Exp Immunol. 2013 Jul;173(1):150-60. doi: 10.1111/cei.12081.
8
Time post-lung transplant correlates with increasing peripheral blood T cell granzyme B and proinflammatory cytokines.
Clin Exp Immunol. 2010 Sep;161(3):584-90. doi: 10.1111/j.1365-2249.2010.04186.x.
9
Compartmentalization of intracellular proinflammatory cytokines in bronchial intraepithelial T cells of stable lung transplant patients.
Clin Exp Immunol. 2006 Sep;145(3):413-9. doi: 10.1111/j.1365-2249.2006.03143.x.
本文引用的文献
1
Intracellular cytokines in blood T cells in lung transplant patients--a more relevant indicator of immunosuppression than drug levels.
Clin Exp Immunol. 2005 Jan;139(1):159-64. doi: 10.1111/j.1365-2249.2005.02671.x.
2
TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells.
J Leukoc Biol. 2004 Jul;76(1):15-24. doi: 10.1189/jlb.1103539. Epub 2004 Feb 13.
3
Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition.
J Am Soc Nephrol. 2004 Feb;15(2):390-7. doi: 10.1097/01.asn.0000108521.39082.e1.
4
Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans?
Transplantation. 2003 Jun 15;75(11):1773-82. doi: 10.1097/01.TP.0000065805.97974.93.
5
Post-transplant renal tubulitis: the recruitment, differentiation and persistence of intra-epithelial T cells.
Am J Transplant. 2003 Jan;3(1):3-10. doi: 10.1034/j.1600-6143.2003.30102.x.
6
C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation.
BioDrugs. 2001;15(5):279-90. doi: 10.2165/00063030-200115050-00001.
7
Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro.
J Immunol Methods. 2001 Jul 1;253(1-2):95-112. doi: 10.1016/s0022-1759(01)00369-6.
8
Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays.
Transplant Proc. 2001 May;33(3):2119-20. doi: 10.1016/s0041-1345(01)01967-4.
9
Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation.
Am J Respir Crit Care Med. 2001 Jan;163(1):259-65. doi: 10.1164/ajrccm.163.1.2005093.
10
Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
J Immunol. 2000 Sep 15;165(6):3444-50. doi: 10.4049/jimmunol.165.6.3444.
Zotero 插件